Treatment Adherence with Early Prescription of Long-Acting Injectable Antipsychotics in Recent-Onset Schizophrenia

Marini, S., Berardis, D. D., Vellante, F., Santacroce, R., Orsolini, L., Valchera, A., Girinelli, G., Carano, A., Fornaro, M., Gambi, F., Martinotti, G., & Giannantonio, M. D. (2016). Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials. Mediators of Inflammation, 2016(), 1044-1051-094. https://doi.org/10.1155/2016/3476240
Mahmoud, A., Hayhurst, K. P., Drake, R. J., & Lewis, S. W. (2011). Second Generation Antipsychotics Improve Sexual Dysfunction in Schizophrenia: A Randomised Controlled Trial. Schizophrenia Research and Treatment, 2011(), 94-99. https://doi.org/10.1155/2011/596898
Rehse, M., Bartolovic, M., Baum, K., Richter, D., Weisbrod, M., & Ely, D. R. (2016). Influence of Antipsychotic and Anticholinergic Loads on Cognitive Functions in Patients with Schizophrenia. Schizophrenia Research and Treatment, 2016(), 61-70. https://doi.org/10.1155/2016/8213165
謝佩樺（2011）。Use of antipsychotics and risk of cerebrovascular events in schizophrenic patients – A nested case-control study〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2011.01569
Wu, C. S., Wu, C. T., & Liu, S. K. (2005). An Open Trial of Risperidone Shifting from Oral Form to Long-acting Injection form in Patients with Schizophrenia. 臺灣精神醫學, 19(4), 314-323. https://doi.org/10.29478/TJP.200512.0007